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doi:10.1Objective: We describe the surgical technique and peroperative management of tracheal and carinal replacement
with aortic allografts for large salivary gland–type carcinoma and report the results with a mean 34 months’ fol-
low-up.
Methods: We performed tracheal and carinal replacements with aortic allografts in 6 patients with extensive mu-
coepidermoid (n ¼ 1) or adenoid cystic (n ¼ 5) carcinomas. Tracheal tumor resection was followed by carinal
restitution (n ¼ 3) and interposition of the graft, splinted by a silicone stent. The allograft consisted of an aortic
segment, either fresh (in the first 2 patients) or cryopreserved (in the last 4). All grafts were wrapped with bulky
and well-vascularized flaps (pectoral muscle flap all patients, with an additional ‘‘thymopericardial fat flap’’ in the
last 2) to promote revascularization and to prevent erosion of adjacent large vessels or fistulas. No immunosup-
pressive therapy was administered.
Results: Complete resection (R0) was achieved in 5 (83%) of 6 patients. Three of the first 4 patients experienced
major morbidity, mainly fistulas between the esophagus and graft. The last 2 patients had an uneventful outcome.
All grafts transformed into well-vascularized conduits focally lined with respiratory epithelium. So far, the last 4
patients are disease-free and 3 of them have returned to full-time employment. Stent removal has not been attemp-
ted in any patient.
Conclusion: Tracheal replacement with aortic allografts enables resection of extensive tumors with a curative
intent. Efficient protective wrap around the graft is mandatory. Further follow-up is required to determine whether
cartilage rings are generated within the graft, as in animal models. (J Thorac Cardiovasc Surg 2010;140:387-93)E
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SSupplemental material is available online.
Despite impressive advances in the field of tracheal surgery,
extensive resection remains challenging and a suitable
tracheal substitute has been sought for decades.1,2
Experimental studies in sheep showed that replacement of
the trachea or carina with fresh3,4 or cryopreserved5 aortic
allografts (AAs), without additional immunosuppression,
produced a neotrachea stiff enough to enable withdrawal of
a stent placed across the AA to prevent collapse. We obtained
similar results in a pig model by replacing long tracheal seg-
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The Journal of Thoracic and Cathese consistent results, we launched in March 2005 a na-
tional tracheal replacement (TR) research program for unre-
sectable tumors. Preliminary results were reported in 2006.8
This article aims at describing the surgical technique, peri-
operative management, recent technical advances, and
results of TR.PATIENTS AND METHODS
Patients
Five men and 1 woman aged 17 to 52 years (mean 34.5 12.8 years) with
large mucoepidermoid (n¼ 1) (MEC) or adenoid cystic (n¼ 5) carcinomas
(ACC) were included in the present study (Table 1). The tumor was revealed
by left recurrent palsy in 1 patient and exertional dyspnea in the others. They
all underwent thorough preoperative functional and oncologic assessment
including pulmonary function tests, chest and upper abdominal computed to-
mography, brain magnetic resonance imaging, positron emission tomogra-
phy, and bronchoscopy with a rigid scope with extensive and deep
biopsies (rigid forceps) to assess the tracheobronchial mucosal and submu-
cosal extension. Esophageal ultrasonography was performed in case of close
contact between the tumor and the esophagus to assess esophageal muscular
layer extension. Owing to the severity of their tracheobronchial obstruction,
4 patients underwent 1 or more tumor debulking endoscopic procedures be-
fore referral, completed by bifurcated silicone stent insertion in 2 patients.
Stents were removed at least 2 weeks before surgery. Diagrams show the
gross tumor extension immediately before surgery (Figure 1).
Preoperative Preparation
Patients were hospitalized 2 to 6 days before surgery for respiratory
physiotherapy and training with noninvasive positive-pressure ventilationrdiovascular Surgery c Volume 140, Number 2 387
Abbreviations and Acronyms
AA ¼ aortic allograft
ACC ¼ adenoid cystic carcinoma
MEC ¼ mucoepidermoid carcinoma
TR ¼ tracheal replacement
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weeks preoperatively.
A percutaneous endoscopic gastrojejunostomy tube was placed preoper-
atively in the last patient to prevent postoperative aspiration. Antibiopro-
phylaxis included co-amoxiclav (6 g/d) administered 24 hours before
surgery and postoperatively for 72 hours. In the last 2 patients, fluconazole
(400 mg/d, 72 hours before surgery and until patients’ discharge) was added
owing to complications experienced by the previous patient.
Fresh and Cryopreserved AAs
For the first 2 patients, 10- to 12-cm long segments of the descending
thoracic aorta harvested from brain-dead donors were provided by the
Agence de la Biome´decine (Saint-Denis la Plaine, France). Subsequently,
we used 10- to 12-cm long cryopreserved segments of the descending tho-
racic aorta of brain-dead donors provided by the European Homograft Bank
(Brussels, Belgium).
Procedures (Table 1)
All patients were positioned supine and conventionally intubated. A me-
dian sternotomy combined with an optional collar incision was performed.
The trachea was exposed by division of the thyroid isthmus, both lobes of
the thymus, and the left innominate vein, followed by a transpericardial ap-
proach to the distal third of the trachea with the vena cava retracted to the
right and the ascending aorta to the left. The carina and both main bronchi
were also exposed, with the right pulmonary artery retracted caudad.
In patient 1, owing to tumor extension (Figure 1), a left thyroid lobec-
tomy was performed first, followed by mediastinal lymph node dissection.
The tracheal tumor was circumferentially dissected (Figure 2, A) and com-
plete removal required a left recurrent nerve and anterior esophageal wall
resection. After withdrawal of the endotracheal tube, the trachea was sec-
tioned below the second ring and distally until the margin was negative
on frozen section analysis (subtotal resection of the main carina) while
unilateral ventilation was ensured through cross-field left main bronchus
cannulation (Figure 2, B).
Carinal restitution was achieved by suturing the right and left main bron-
chi together with 3-0 absorbable Monosyn (Aesculap, Tutlingen, Germany)
glyconate monofilament interrupted sutures. End-to-end anastomosis be-
tween the proximal trachea and the fresh AA was then performed with
a Monosyn glyconate 3-0 running suture (Figure 2, C). With the apneic hy-
peroxygenation technique,9 tracheal and bronchial limbs of a Y-shaped sil-
icone stent (Tracheobronxane Dumon; Novatech, Aubagne, France) were
checked to fit the length of both main bronchi and trachea to be replaced.
Once the left main bronchus was recannulated, the patient was orotracheally
intubated with a rigid bronchoscope. Through the operative field, the folded
stent was entered into the AA and gently pulled above the proximal anasto-
mosis (Figure 2, D). The distal part of the AA and new carina were then ap-
proximated with a posterior hemicircumferential running suture. The left
main bronchus was extubated and jet ventilation was applied through the
bronchoscope. The stent was pushed down and the bronchial limbs entered
into both main bronchi (Figure 2, E). The distal anastomosis was then com-
pleted with interrupted sutures (Figure E1). To avoid postoperative dis-
placement, we secured the stent proximally and distally with transfixiant
2-0 nonabsorbable Dafilon (Aesculap, Tutlingen, Germany) sutures and
the patient was then conventionally reintubated (Figure 2, F).388 The Journal of Thoracic and Cardiovascular SurgTo promote revascularization of the graft and prevent erosion of contig-
uous large vessels, we partially wrapped the graft with a right pectoral mus-
cle flap based on its thoracoacromial blood supply, which was elevated and
transferred intrathoracically through a transparietal window performed by
resection of the first costal cartilage (Figures 3 and E2). The sternum was
closed after pleural and mediastinal tube placement. A double jejunostomy
was performed through a left-sided minilaparotomy to prevent postopera-
tive aspiration, allowing placement of a retrograde transpyloric gastric suc-
tion tube for gastric emptying and a second anterograde tube enabling
enteral feeding.
In patient 2, the procedure started with mediastinal lymph node dissec-
tion. Owing to tumor extension (Figures 1 and E3), the trachea was sec-
tioned just below the first cartilage and distally, after a right upper
lobectomy, the entire right main bronchus and both first cartilages of the
left main bronchus were resected (Figure E3). After a right hilar release,
carinal restitution was achieved by suturing the bronchus intermedius and
the left main bronchus together. Before reconstruction, since the patient
poorly tolerated unilateral cross-field ventilation, the bronchus intermedius
also needed to be cannulated to achieve satisfactory ventilation. The rest of
the procedure was similar to that of patient 1.
In patient 3, mediastinal lymph node dissection with preservation of the
left recurrent nerve was performed first. The tumor was circumferentially
dissected from the aortic arch and left pulmonary artery. The left main
bronchus was sectioned proximally and cannulated to achieve unilateral
cross-field ventilation. A 5.5-cm long tracheal and carinal resection was
then performed, according to frozen section (Figure 1). A right U-shaped hi-
lar release and blunt dissection of the pretracheal plane were performed.
Since approximation of the trachea to the right main bronchus failed, despite
maximal cervical flexion, a cryopreserved AA splinted by a custom-made
silicone stent (Tracheobronxane Dumon; Novatech, La Ciotat, France)
was interposed with end-to-end proximal and distal anastomoses. After con-
ventional reintubation, the right lung was inflated and ventilated. The left
pulmonary artery and veins were then divided with endostapler devices
(Endopath; Ethicon Endo-surgery, Cincinnati, Ohio) and the left lung was
removed through a transpleural approach. Last, the graft was partially wrap-
ped by means of a left pectoral muscle flap.
In patient 4, tumor-free airway margins required tracheal section below
the sixth cartilaginous ring, followed by 10- and 15-mm long resection of
the right and left main bronchi, respectively (Figure 1). After bilateral hilar
release and restitution of a new carina, an 85-mm long TR was performed
with a cryopreserved AA, followed by a wrap as previously described. Dur-
ing resection and reconstruction steps, dual lung ventilation was required to
achieve satisfactory gas exchange.
In patient 5, tumor-free margin resection required 10.5-cm long tracheal
and left recurrent nerve resections (Figure 1). To improve the graft wrap, we
used a novel flap, the ‘‘thymopericardial fat flap’’ based on the internal tho-
racic artery blood supply, including the right internal thoracic pedicle, right
thymic lobe, and entire homolateral pericardial fat, which was harvested by
freeing up to the thoracic wall, ascending aorta, and pericardium and mobi-
lized to create an interposition between the splinted cryopreserved AA and
the esophagus. The wrap was completed by means of a right pectoral muscle
flap, as previously described (Figure 4). Finally, a double jejunostomy was
performed through a left-sided minilaparotomy.
In patient 6, complete tumor removal required a 9-cm long tracheal
(Figure 1), left recurrent nerve, and muscular layer esophageal resection.
Cryopreserved AA wrap was similar to that of patient 5. Owing to sternal
dehiscence experienced by patients 1 and 5, the sternum was closed by using
titanium clip devices (ASCO10; Vitalitec, Domalin, France).Information and Consent
The national TR research program was approved by the French Bioethics
Advisory Board, the French Agency for Health Safety (AFSSAPS), and
our institutional reviewboard. Informedconsent was obtained fromall patients.
In patients 2, 4, and 5, these requirements significantly delayed the procedure.ery c August 2010
TABLE 1. Tracheal replacement with aortic allografts: Procedures and pathology
Patient no.
(date)
Age
(y) Sex
Diagnosis
delay before
procedure (mo)
Length of
resection
(mm)
Additional
procedures
Aortic
allografts Wrap
Duration of
procedure
(min) Pathology
No. of stent
changes or
shortenings
1 (March 31, 2005) 46 M MEC (1) 90 (CRR) EMLR GJ FAA PMF 710 R1
1Nþ, 4N
3
2 (April 22, 2005) 17 M ACC (28) 110 (CRR) Right upper lobectomy FAA PMF 540 R0
21 N
4
3 (May 31, 2006) 30 M ACC (5) 55 (CR) Left pneumonectomy CAA PMF 780 R0
2Nþ, 15N
11
4 (July 17, 2006) 27 F ACC (11) 85 (CRR) — CAA PMF 570 R0
17 N
3
5 (June 4, 2007) 52 M ACC (6) 105 GJ CAA PMF
TPF
615 R0
2Nþ, 26N
3
6 (Sept 14, 2007) 35 M ACC (5) 90 EMLR
percutaneous GJ
CAA PMF
TPF
575 R0
12 N
2
M, Male; F, female; MEC, mucoepidermoid carcinoma; ACC, adenoid cystic carcinoma; CRR, carinal resection and restitution; CR, carinal resection; EMLR, esophagus muscular
layer resection; GJ, gastrostomy and jejunostomy; FAA, fresh aortic allograft; CAA, cryopreserved aortic allograft; PMF, pectoral muscle flap; TPF, thymopericardial fat flap; R1,
margin positive; R0, margin negative; Nþ, lymph node positive; N, lymph node negative.
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RESULTS
Pathology Findings
Frozen section of the gross tumor showed positive tra-
cheal and/or bronchial margins in all patients. Accordingly,
an average of 5.3 (range 4–9) additional tracheal or bron-
chial sections were required per patient to ensure the absence
of tumor on frozen section analysis.
In patient 1 (low-grade MEC), 1 of the 5 resected lymph
nodes showed juxtatumoral metastasis (2L). Although fro-
zen sections were negative, final pathologic study of the dis-
tal airway margin (left main bronchus) showed microscopic
invasion of the peribronchial adventitia (R1 resection).
In all other patients (ACC), proximal and distal airway
margins were found to be disease-free (R0 resections). A
mean of 19  6 (range 12–28) lymph nodes were resected.
Patients 3 and 5 showed lymphatic spread in 2 nodes
(Table 1).
Postoperative Course
All patients were extubated in the operating room. Be-
cause of ineffective cough, intensive physiotherapy and
daily treatments with a fiberoptic bronchoscope were
required in the early postoperative course.
In patient 1, limited dehiscence of the proximal anastomo-
sis required suture on day 13 and sternoplasty for incomplete
separation of the sternum on day 15. The patient was dis-
charged on day 40.
In patient 2, acute anterior spinal cord ischemia developed
on day 1. Definitive explanation of this severe complication
remains elusive. Several factors, including microemboliThe Journal of Thoracic and Camigrating via the left vertebral artery arising from the aortic
arch and/or tumor-related thrombophilia, may have played
a role. Severe distortion of the bronchus intermedius, distal
to the right limb of the stent, was responsible for purulent re-
tention and required additional bronchial stenting (Ultraflex
self-expandable metallic stent; Boston Scientific, Natick,
Mass) on day 31. The patient was transferred on day 58 to
the regional spinal cord injury rehabilitation center.
In patient 3, pneumonia developed on day 3 and a trache-
otomy was done on day 5. He was weaned from the ventila-
tor on day 15 and was discharged on day 30.
Patient 4 showed partial necrosis of the graft related to
invasive fungal infection (Candida albicans), which re-
quired retransplantation on day 18. The wrap was completed
by using an omental flap that was transferred intrathoraci-
cally through a substernal route. Acute respiratory distress
syndrome required tracheostomy and prolonged mechanical
ventilation. On day 32, a fistula between the neocarina and
the esophagus required emergency placement of gastro-
stomy and jejunostomy suction tubes. She was discharged
on day 90 with a minitracheostomy tube that maintained
the stent in a stable position and allowed on-demand tra-
cheobronchial self-suctioning.
Patient 5 required intermittent noninvasive positive-
pressure ventilatory support for 10 days. He experienced
sternal dehiscence on day 18, treated by sternoplasty with
titanium clip devices, and he was discharged on day 30.
Patient 6 had an uneventful postoperative course, and he
was discharged on day 29.Midterm Outcome
In patients, stent maintenance required appropriate hu-
midification (aerosol twice a day) and quarterly follow-up
bronchoscopy.rdiovascular Surgery c Volume 140, Number 2 389
FIGURE 1. Gross tumor extension, proximal and distal sections of the airway, in patients 1 to 6 (double arrows).
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SStent removal was attempted at 21 and 24 months in pa-
tients 1 and 2, respectively. Both patients were found to
have a 0.5 cm large esophageal fistula, which was asymp-
tomatic so long as the tracheobronchial stent was present.
Additionally, the graft was not stiff enough to maintain a pat-
ent airway, so that after several days, both patients had a new
bifurcated stent inserted to splint the central airway. In pa-
tient 2, a surgical attempt to close the fistula failed and the
patient died of massive hemoptysis 26 months after TR.
In patient 3, instability of the stent led to several stent
changes: straight silicone stents (n ¼ 3) changed to self-
expandable covered metallic stents (n ¼ 7) and then to
a straight silicone stent placed across the right upper lobe
orifice with a lateral window to facilitate ventilation and390 The Journal of Thoracic and Cardiovascular Surgclearance of secretions, which currently has been in place
for 15 months (Table 1). At 6 months, partial disruption of
the lower anastomosis required surgical closure, buttressed
by a contralateral pectoral muscle flap. Last, a straight
back syndrome developed at 27 months, treated successfully
by partial manubrium sterni resection.10
In patient 4, closure of the carinal fistula and colonic
esophagoplasty were performed 1 year after retransplanta-
tion. The postoperative course was complicated by acute re-
spiratory distress syndrome and clinically unapparent
anterior wall graft disruption. The patient was discharged
on day 81, and subsequent chest computed tomographic
follow-up demonstrated closure of the graft disruption.
The midterm course was uneventful in patients 5 and 6.ery c August 2010
FIGURE 2. Main steps of the procedure, in patient 1. A, Orotracheal intubation and ventilation; circumferential tumor dissection (large arrow); removal of
the gross tumor extension (double arrows). B, Withdrawal of the endotracheal tube and cross-field left main bronchus cannulation; distal sections after frozen
section analysis (double arrows). C, Carinal restitution by suturing the right and left main bronchi together; end-to-end anastomosis between the proximal
trachea and aortic allograft. D, Orotracheal intubation with a rigid bronchoscope; the folded stent was pulled with a forceps introduced through the broncho-
scope. E, Jet ventilation was applied through the bronchoscope; the bifurcated stent was gently pushed caudally with a forceps. F, The anterior distal anas-
tomosis was completed and the patient was conventionally reintubated.
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Twenty months after TR, slowly progressive metastatic
disease refractory to chemotherapy developed in patient 1,
who died 45 months after TR without evidence of local re-
lapse. Patient 2 was disease-free before death, 26 months af-
ter TR. No postmortem examination could be performed in
either patient.
Four patients are alive and disease-free so far, with a mean
follow-up of 34 months (range 26–42 months). Three of
them returned to full-time employment (patients 3, 5, and 6).Graft Transformation
Within the first weeks of TR, bronchoscopic examinations
through the translucent stents showed a progressive transfor-
mation of the whitish internal face of aortic grafts into a pink,
highly vascularized conduit. In 3 patients, a fistula devel-
oped between the graft and the esophagus. One of these
(in patient 4) was large enough to be seen through the stent
at day 32 after retranplantation; the others were discovered
in patients 1 and 2 once the stent had been removed (at 21
and 24 months, respectively). As seen in experimental stud-
ies,3-7 4 patients showed sparse calcifications suggestive of
osseous metaplasia within the graft (follow-up computed
tomography). Six months after TR, follow-up also showed
progressive contraction of the graft (mean 28%  10%;
range 15%–40%). This required serial endoscopic proce-
dures for tracheal limb shortening or stent replacementsThe Journal of Thoracic and Ca(Table 1), which provided the opportunity to appreciate
the stiffness of the graft. None of the patients experienced
acute airway collapse when their stent was removed, thereby
attesting to some degree of graft stiffness. At the end of
‘‘free-of-stent periods,’’ which ranged from 12 to 21 days,
the graft consistently showed centripetal shrinking as seen
in experimental studies.3-7 At this time, no patient has
a graft stiff enough to allow definitive stent withdrawal.
Superficial biopsies of the middle part of the graft per-
formed 1 year after TR in patients 1 and 2 showed an internal
surface focally lined with respiratory epithelium and residual
islets of elastic fibers of aortic implant with dense inflamma-
tory infiltrate within the graft (Figure E4). In patient 1, these
microscopic features were persistent 43 months after TR. In
patients 5 and 6, the biopsy specimens were more superficial
and showed conjunctive tissue with dense inflammatory
infiltrate, without evidence of residual elastic tissue, and
focally lined by squamous metaplasia (patient 5) or without
surface epithelium (patient 6).DISCUSSION
ACCs and low-grade MECs of the trachea are rare, slow-
growing tumors usually associated with prolonged survival.
ACCs spread by direct extension, perineural invasion, and to
the tracheal mucosa without altering the overall architecture.
Thus, endoscopic and peroperative examination may under-
estimate the tumor spread. Nodal metastases are relativelyrdiovascular Surgery c Volume 140, Number 2 391
FIGURE 4. Complete wrap. ‘‘Thymopericardial fat flap’’ with its right in-
ternal thoracic pedicle, on the right and posterior face of graft, and the right
pectoral muscle flap interposed between the graft and large vessels (patients
5 and 6).
FIGURE 3. Partial wrap. Pectoral muscle flap interposed between the
splinted aortic allograft and the large vessels (patients 1 to 4).
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Distant metastases tend to occur, mainly to the lung, and
may remain silent for many years. Low-grade MECs are
mainly endoluminal, polypoid, and noninvasive tumors.
Lymphatic spread and distant metastases are unusual and
their prognosis after complete resection is excellent.13,14
Treatment options include resection reconstructed by pri-
mary anastomosis, whenever possible, radiotherapy, or
a combination of these. In ACC, the extent of resection re-
mains controversial. Maziak and associates12 demonstrated
excellent long-term palliation after both complete and in-
complete (tracheal margin positive) resection followed by
postoperative radiotherapy. In contrast, Gaissert and col-
leagues11 demonstrated that complete resection with a nega-
tive air margin resulted in higher survival than did
incomplete resection or unresectable tumors. There was no
survivor beyond 13 years in the unresectable group, whereas
survival after incomplete resection at 15 years was 14.5%.
In patients with unresectable tumors, radiotherapy with or
without intraluminal brachytherapy can lead to long-term
survival and occasionally to cure.15 Last, a recent case report
suggests that some primary tracheal ACCs may respond to
a combination of carboplatin/paclitaxel and 3-dimensional
conformal radiation therapy.16
In both resectable and unresectable groups, tumor debulk-
ing endoscopic procedures can be effective in relieving air-
way obstruction before surgery, radiation therapy, or
palliative stent placement.
In the present study, in which surgery with a curative in-
tent was the treatment option, the extent of the airway defect
after resection of the gross tumor precluded reconstruction
by primary anastomosis and TR was mandatory. Micro-
scopic examination of the resection lines was essential to en-
sure tumor clearance, and an average of 5.3 tracheal or
bronchial sections was required to obtain safe margins on
frozen section analysis. However, despite 9 tracheal sec-
tions, the patient with MEC was found to have a positive392 The Journal of Thoracic and Cardiovascular Surgdistal margin on final pathologic study. TR allowed us to
perform such large resections reconstructed by interposition
of either fresh or cryopreserved AAs, the latter being readily
available in tissue banks and bacteriologically safe.7 On the
other hand, the additional mediastinal lymph node dissection
led to skeletonization of the mediastinum and weakened the
vascularization of surrounding stuctures. Therefore, wrap-
ping of the graft was mandatory to prevent life-threatening
complications such as arterial erosion4,12 and to promote
angiogenesis within the AA. The first 4 patients received
a partial wrap, by using a pectoral muscle flap, according
to our previous experience17 and experimental study in a ca-
nine model, demonstrating satisfactory viability in either
fresh or cryopreserved tracheal autografts implanted in ab-
dominal wall muscle.18 Despite this precaution, esophageal
fistula was observed in 3 of 4 patients, a complication that
had never been described in animal models.3-7 The fistula
was most likely the consequence of a focal graft necrosis
and lack of posterior wrap interposed between the graft
and the esophagus. Subsequently, we devised the
‘‘thymopericardial fat flap’’ to complete the wrap and
protect from fistula of the esophagus. Outcome was
noticeably uneventful in both patients with such a double
flap. Despite the absence of immunosuppressive therapy,
none of the patients had acute or chronic graft rejection
phenomenon. This was consistent with prior results of
orthotopic transplantation of AAs in humans and
heterotopic transplantation in animal models.3-7 In the
patient with MEC and a positive distal margin, no
radiotherapy was administered, according to the low-grade
status of the tumor14 and to the absence of knowledge re-
garding potential harmful consequences of AA irradiation.
The remaining patients did not undergo radiotherapy either,
because their resection was complete19 and the benefit of ra-
diation therapy in patients’ survival has never been demon-
strated by randomized trials.12 In agreement with previousery c August 2010
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Sexperience in animal models, significant graft shrinking3-7,20
and likely osseous metaplasia3-7 were observed in our
patients. Although the heterotopic AA transformed into
a well-vascularized conduit focally lined with respiratory ep-
ithelium, it is so far unclear whether cartilage rings are gen-
erated within the graft, as in animal models, and whether the
stent can be definitively removed without adverse effect.
As yet, with a mean follow-up time of 34 months, this
clinical study might be considered as an intermediate result
in terms of patient survival, with regard to the low-grade sta-
tus of the tumor. Although the 4 patients still alive are
disease-free so far, longer follow-up is needed to evaluate
the benefits of this novel procedure in terms of survival, in
comparison with incomplete resection followed by radio-
therapy11,12 or most recent chemoradiotherapy.16
In the field of central airway replacement, tissue engineer-
ing is a promising technique as well. Although Walles and
associates21 elegantly demonstrated that a bioartificial tra-
chea could be engineered on a vascularized scaffold, the en-
gineered trachea still lacked the 3-dimensional aspect and
the biomedical profile of a functioning trachea. These diffi-
culties might be resolved by using in situ tissue engineering
with a collagen-conjugated airway prosthesis and omental
wrap22,23 or by using bioengineered human airways.24
Thus, biologic and synthetic scaffold for host tissue regener-
ation are in competition in the field of central airway replace-
ment and we await the clinical application of these
techniques, mainly in the challenging procedures of intra-
thoracic tracheal and carinal replacement. From a practical
point of view, we emphasize the importance of effective
graft wrap with bulky and well-vascularized flaps, which-
ever tracheal substitute might be used.
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FIGURE E1. A, Carinal restitution in patient 1. RMB, Right main bronchus; LMB, left main bronchus. B, Operative view of the tracheal reconstruction with
the fresh aortic allograft in place, in patient 1. IA, Innominate artery; AA, aortic allograft.
FIGURE E2. Operative view of interposition of the pectoral muscle flap
between the graft and large vessels, in patient 1. IA, Innominate artery;
AO, aorta.
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FIGURE E3. A, Chest computed tomographic scan in patient 2. The arrows show the upper and lower limits of the tumor. B, Tracheal and carinal resection
specimen including the stapled bronchial stump of the right upper lobe. RUB, Right upper lobe bronchus, LMB, left main bronchus.
FIGUREE4. A, Normal respiratory epithelium and basement membrane lining the graft (arrow), in patient 1 (hematoxylin–eosin stain3100). B, Persistence
of islet of elastic fibers (arrows) within a dense inflammatory infiltrate in patient 1 (hematoxylin–eosin stain 3400).
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